• 1
    Li XF, Fortney JA, Kotelchuck M, Glover LH. The postpartum period: the key to maternal mortality. Int J Gynecol Obstet 1996;54:110.
  • 2
    Lewis G, editor, CEMACH. Why Mothers Die 2003–2005––Seventh Report of the Confidential Enquires into Maternal Deaths in the United Kingdom. London: RCOG Press, 2007.
  • 3
    McCormick ML, Sanghvi HC, Kinzie B, McIntosh N. Preventing postpartum hemorrhage in low-resource settings. Int J Gynecol Obstet 2002;77:26775.
  • 4
    McDonald S, Prendiville WJ, Elbourne D. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software; 2004.
  • 5
    McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. BMJ 1993;307:116771.
  • 6
    Carey M. Adverse cardiovascular sequelae of ergometrine. Br J Obstet Gynaecol 1993;100:865.
  • 7
    Dumoulin JG. A reappraisal of the use of ergometrine. J Obstet Gynecol 1981;1:17881.
  • 8
    Mitchell GG, Elbourne DR. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. Online J Curr Clin Trials 1993; Doc No 83.
  • 9
    Yuen PM, Chan NS, Yim SF, Chang AM. A randomized double blind comparison of Syntometrine and Syntocinon in the management of the third stage of labour. Br J Obstet Gynaecol 1995;102:37780.
  • 10
    Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software; 2004.
  • 11
    Chong YS, Su LL, Arulkumaran S. Current strategies for the prevention of postpartum haemorrhage in the third stage of labour. Curr Opin Obstet Gynecol 2003;16:14350.
  • 12
    Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992;52:6067.
  • 13
    Boucher M, Horbay GL, Griffin P, Deschamps Y, Desjardins C, Schulz M, et al. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing caesarean section. J Perinatol 1998;18:2027.
  • 14
    Dansereau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after caesarean section. Am J Obstet Gynecol 1999;180:6706.
  • 15
    Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage. In: The Cochrane Database of Systematic Reviews Issue 3. Oxford: Update Software; 2007.
  • 16
    Duthie SJ, Ven D, Yung GL, Guang DZ, Chan SY, Ma HK. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 1991;38:11924.
  • 17
    Razvi K, Chua S, Arulkumaran S, Ratnam SS. A comparison between visual estimation and laboratory determination of blood loss during the third stage of labour. Aust N Z J Obstet Gynaecol 1996;36:1524.
  • 18
    Larsson C, Saltvedt S, Wiklund I, Pahlen S, Andolf E. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand 2006;85:144852.
  • 19
    Boucher M, Nimrod CA, Tawagi GF, Meeker TA, Rennicks White RE. Comparison of carbetocin and oxytocin for the prevention of postpartum haemorrhage following vaginal delivery: a double-blind randomized trial. J Obstet Gynecol Can 2004;26:4818.
  • 20
    Leung SW, Ng PS, Wong WY, Cheung TH. A randomized trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG 2006;113:145964.